Yatharth Hospital & Trauma Care Services Ltd

YATHARTHHospital
587.20+0.00 (+0.00%)
As on 30 Jan 2026, 01:40 pmMarket Closed

Fundamental Score

...

Yatharth Hospital & Trauma Care Services Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

10.43%
Poor

Return on Capital Employed

13.99%
Excellent

Operating Profit Margin (5Y)

28.19%
Poor

Dividend Yield

0.00%

Valuation Metrics

Good

Price to Earnings

45.28x

Market Capitalization

6.90K (Cr)

Industry P/E

52.84x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

33.25%
Excellent

YoY Quarterly Sales Growth

28.31%
Excellent

Sales Growth (5Y)

44.60%
Excellent

EPS Growth (5Y)

80.02%
Excellent

Profit Growth (5Y)

151.91%

Financial Health

Excellent

Debt to Equity

0.02x
Excellent

Interest Coverage

59.10x
Poor

Free Cash Flow (5Y)

-169.60 (Cr)

Ownership Structure

Good

Promoter Holding

61.64%
Average

FII Holding

6.51%
Average

DII Holding

8.71%
Average

Pledged Percentage

15.33%
Market-cap Classification
Mid-cap
Balance of growth potential and stability.
61.64%
Promoter Holding
6.90K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of YATHARTH across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Operating Margins (28.19%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Robust Profit Growth (33.25%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (28.31%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (44.60% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Excellent EPS Growth (80.02% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (151.91% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Conservative Debt Levels (D/E: 0.02)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Interest Coverage (59.10x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (61.64%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Risk Factors

4 factors identified

Premium Valuation Risk (P/E: 45.28x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Negative Free Cash Flow (₹-169.60 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Financial Statements

Comprehensive financial data for Yatharth Hospital & Trauma Care Services Ltd

About YATHARTH

Business Overview

Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney transplant, IVF and fertility, emergency medicine, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, nutrition and health, interventional spine and pain medicine, neurology, neurosurgery, and cardiovascular and thoracic surgery. In addition, the company sells medicines and canteen food. The company was incorporated in 2008 and is based in Noida, India.

Company Details

Symbol:YATHARTH
Industry:Hospital
Sector:Hospital

Key Leadership

Mr. Ajay Kumar Tyagi
Chairman & Whole-time Director
Mr. Amit Kumar Singh
Group Chief Executive Officer
Mr. Pankaj Prabhakar
Chief Financial Officer

YATHARTH Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)10.43%
Return on Capital Employed13.99%
Operating Profit Margin (5Y)28.19%
Debt to Equity Ratio0.02
Interest Coverage Ratio59.10

Growth & Valuation

Sales Growth (5Y)44.60%
Profit Growth (5Y)151.91%
EPS Growth (5Y)80.02%
YoY Quarterly Profit Growth33.25%
YoY Quarterly Sales Growth28.31%

Frequently Asked Questions

What is the current price of Yatharth Hospital & Trauma Care Services Ltd (YATHARTH)?

As of 30 Jan 2026, 01:40 pm IST, Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) is currently trading at ₹587.20. The stock has a market capitalization of ₹6.90K (Cr).

Is YATHARTH share price Overvalued or Undervalued?

YATHARTH is currently trading at a P/E ratio of 45.28x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Yatharth Hospital & Trauma Care Services Ltd share price?

Key factors influencing YATHARTH's price include its quarterly earnings growth (Sales Growth: 28.31%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Yatharth Hospital & Trauma Care Services Ltd a good stock for long-term investment?

Yatharth Hospital & Trauma Care Services Ltd shows a 5-year Profit Growth of 151.91% and an ROE of 10.43%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.02 before investing.

How does Yatharth Hospital & Trauma Care Services Ltd compare with its industry peers?

Yatharth Hospital & Trauma Care Services Ltd competes with major peers in the Hospital. Investors should compare YATHARTH's P/E of 45.28x and ROE of 10.43% against the industry averages to determine its competitive standing.

What is the P/E ratio of YATHARTH and what does it mean?

YATHARTH has a P/E ratio of 45.28x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹45 for every ₹1 of annual earnings.

How is YATHARTH performing according to Bull Run's analysis?

YATHARTH has a Bull Run fundamental score of 61.7/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does YATHARTH belong to?

YATHARTH operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Yatharth Hospital & Trauma Care Services Ltd.

What is Return on Equity (ROE) and why is it important for YATHARTH?

YATHARTH has an ROE of 10.43%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Yatharth Hospital & Trauma Care Services Ltd generates profits from shareholders' equity.

How is YATHARTH's debt-to-equity ratio and what does it indicate?

YATHARTH has a debt-to-equity ratio of 0.02, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is YATHARTH's dividend yield and is it a good dividend stock?

YATHARTH offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has YATHARTH grown over the past 5 years?

YATHARTH has achieved 5-year growth rates of: Sales Growth 44.60%, Profit Growth 151.91%, and EPS Growth 80.02%.

What is the promoter holding in YATHARTH and why does it matter?

Promoters hold 61.64% of YATHARTH shares, with 15.33% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is YATHARTH's market capitalization category?

YATHARTH has a market capitalization of ₹6905 crores, placing it in the Mid-cap category.

How volatile is YATHARTH stock?

YATHARTH has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for YATHARTH?

YATHARTH has a 52-week high of ₹N/A and low of ₹N/A.

What is YATHARTH's operating profit margin trend?

YATHARTH has a 5-year average Operating Profit Margin (OPM) of 28.19%, indicating the company's operational efficiency.

How is YATHARTH's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 28.31% and YoY Profit Growth of 33.25%.

What is the institutional holding pattern in YATHARTH?

YATHARTH has FII holding of 6.51% and DII holding of 8.71%. Significant institutional holding often suggests professional confidence in the stock.